Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line

S. P. Ivy, A. Tulpule, C. R. Fairchild, S. D. Averbuch, C. E. Myers, D. W. Nebert, W. M. Baird, Kenneth H Cowan

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

MCF-7 human breast cancer cells, selected for resistance to adriamycin (Adr(R)), exhibit the phenotype of multidrug resistance (MDR). Previous studies have shown that resistance in Adr(R) MCF-7 cells is associated with several biochemical changes that are similar to those induced in rat hyperplastic nodules, preneoplastic liver lesions which display broad spectrum resistance to carcinogens and hepatotoxins. In this report, we show that these changes in the Adr(R) MCF-7 cells are also associated with the development of cross-resistance to the procarcinogen benzo(a)pyrene (BP) and are associated with a marked defect in the conversion of BP to its cytotoxic, carcinogenic metabolites by Adr(R) cells. Since aryl hydrocarbon hydroxylase in the principle enzyme activity which converts benzo(a)pyrene to toxic hydroxylated forms, the regulation of cytochrome P-450IA1 expression, the gene encoding this enzyme activity in MCF-7 cells, was examined. Incubation with 100 nM 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for 24 h results in a marked increase in aryl hydrocarbon hydroxylase activity in wild type (WT) but not Adr(R) MCF-7 cells. The alteration in aryl hydrocarbon hydroxylase expression in the Adr(R) cells is not overcome by incubation either with higher concentrations of TCDD (1 μM) or for longer periods of time (4 days). Northern blot analysis indicates that this defect in Adr(R) MCF-7 cells involves a regulatory defect at the level of P-450IA1 RNA. Following transfection of a construct containing the normal mouse P-450IA1 promoter fused to a reporter gene (bacterial chloramphenicol acetyltransferase) into WT and Adr(R) MCF-7 cells, TCDD induced chloramphenicol acetyltransferase activity in WT MCF-7 cells only. Furthermore, TCDD also induces both DT-diaphorase and UDP-glucuronyltransferase activities in WT, but not Adr(R) cells. These data suggest that the defect in the Adr(R) MCF-7 cells is not due to a structural P-450IA1 gene mutation, but rather involves a product regulating the polycyclic hydrocarbon-inducible expression of several drug-metabolizing enzyme activities. This defect in the Adr(R) MCF-7 cells is also associated with the development of resistance to ellipticine, an anticancer agent which is converted to more toxic hydroxylated species by aryl hydrocarbon hydroxylase or a similar mixed function oxidase. The WT and Adr(R) MCF-7 cells represent a useful model to study the regulation of the P-450IA1 gene in human cells.

Original languageEnglish (US)
Pages (from-to)19119-19125
Number of pages7
JournalJournal of Biological Chemistry
Volume263
Issue number35
StatePublished - Dec 1 1988

Fingerprint

MCF-7 Cells
Aryl Hydrocarbon Hydroxylases
Cells
Breast Neoplasms
Enzyme activity
Cell Line
Defects
Chloramphenicol O-Acetyltransferase
Genes
Poisons
Benzo(a)pyrene
ellipticine
Cyclic Hydrocarbons
NAD(P)H Dehydrogenase (Quinone)
Glucuronosyltransferase
Gene encoding
Uridine Diphosphate
Cytochromes
Metabolites
Mixed Function Oxygenases

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Ivy, S. P., Tulpule, A., Fairchild, C. R., Averbuch, S. D., Myers, C. E., Nebert, D. W., ... Cowan, K. H. (1988). Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. Journal of Biological Chemistry, 263(35), 19119-19125.

Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. / Ivy, S. P.; Tulpule, A.; Fairchild, C. R.; Averbuch, S. D.; Myers, C. E.; Nebert, D. W.; Baird, W. M.; Cowan, Kenneth H.

In: Journal of Biological Chemistry, Vol. 263, No. 35, 01.12.1988, p. 19119-19125.

Research output: Contribution to journalArticle

Ivy, SP, Tulpule, A, Fairchild, CR, Averbuch, SD, Myers, CE, Nebert, DW, Baird, WM & Cowan, KH 1988, 'Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line', Journal of Biological Chemistry, vol. 263, no. 35, pp. 19119-19125.
Ivy SP, Tulpule A, Fairchild CR, Averbuch SD, Myers CE, Nebert DW et al. Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. Journal of Biological Chemistry. 1988 Dec 1;263(35):19119-19125.
Ivy, S. P. ; Tulpule, A. ; Fairchild, C. R. ; Averbuch, S. D. ; Myers, C. E. ; Nebert, D. W. ; Baird, W. M. ; Cowan, Kenneth H. / Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. In: Journal of Biological Chemistry. 1988 ; Vol. 263, No. 35. pp. 19119-19125.
@article{98e4cb10620d411ea3eac35ee8c7ba0c,
title = "Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line",
abstract = "MCF-7 human breast cancer cells, selected for resistance to adriamycin (Adr(R)), exhibit the phenotype of multidrug resistance (MDR). Previous studies have shown that resistance in Adr(R) MCF-7 cells is associated with several biochemical changes that are similar to those induced in rat hyperplastic nodules, preneoplastic liver lesions which display broad spectrum resistance to carcinogens and hepatotoxins. In this report, we show that these changes in the Adr(R) MCF-7 cells are also associated with the development of cross-resistance to the procarcinogen benzo(a)pyrene (BP) and are associated with a marked defect in the conversion of BP to its cytotoxic, carcinogenic metabolites by Adr(R) cells. Since aryl hydrocarbon hydroxylase in the principle enzyme activity which converts benzo(a)pyrene to toxic hydroxylated forms, the regulation of cytochrome P-450IA1 expression, the gene encoding this enzyme activity in MCF-7 cells, was examined. Incubation with 100 nM 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for 24 h results in a marked increase in aryl hydrocarbon hydroxylase activity in wild type (WT) but not Adr(R) MCF-7 cells. The alteration in aryl hydrocarbon hydroxylase expression in the Adr(R) cells is not overcome by incubation either with higher concentrations of TCDD (1 μM) or for longer periods of time (4 days). Northern blot analysis indicates that this defect in Adr(R) MCF-7 cells involves a regulatory defect at the level of P-450IA1 RNA. Following transfection of a construct containing the normal mouse P-450IA1 promoter fused to a reporter gene (bacterial chloramphenicol acetyltransferase) into WT and Adr(R) MCF-7 cells, TCDD induced chloramphenicol acetyltransferase activity in WT MCF-7 cells only. Furthermore, TCDD also induces both DT-diaphorase and UDP-glucuronyltransferase activities in WT, but not Adr(R) cells. These data suggest that the defect in the Adr(R) MCF-7 cells is not due to a structural P-450IA1 gene mutation, but rather involves a product regulating the polycyclic hydrocarbon-inducible expression of several drug-metabolizing enzyme activities. This defect in the Adr(R) MCF-7 cells is also associated with the development of resistance to ellipticine, an anticancer agent which is converted to more toxic hydroxylated species by aryl hydrocarbon hydroxylase or a similar mixed function oxidase. The WT and Adr(R) MCF-7 cells represent a useful model to study the regulation of the P-450IA1 gene in human cells.",
author = "Ivy, {S. P.} and A. Tulpule and Fairchild, {C. R.} and Averbuch, {S. D.} and Myers, {C. E.} and Nebert, {D. W.} and Baird, {W. M.} and Cowan, {Kenneth H}",
year = "1988",
month = "12",
day = "1",
language = "English (US)",
volume = "263",
pages = "19119--19125",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "35",

}

TY - JOUR

T1 - Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line

AU - Ivy, S. P.

AU - Tulpule, A.

AU - Fairchild, C. R.

AU - Averbuch, S. D.

AU - Myers, C. E.

AU - Nebert, D. W.

AU - Baird, W. M.

AU - Cowan, Kenneth H

PY - 1988/12/1

Y1 - 1988/12/1

N2 - MCF-7 human breast cancer cells, selected for resistance to adriamycin (Adr(R)), exhibit the phenotype of multidrug resistance (MDR). Previous studies have shown that resistance in Adr(R) MCF-7 cells is associated with several biochemical changes that are similar to those induced in rat hyperplastic nodules, preneoplastic liver lesions which display broad spectrum resistance to carcinogens and hepatotoxins. In this report, we show that these changes in the Adr(R) MCF-7 cells are also associated with the development of cross-resistance to the procarcinogen benzo(a)pyrene (BP) and are associated with a marked defect in the conversion of BP to its cytotoxic, carcinogenic metabolites by Adr(R) cells. Since aryl hydrocarbon hydroxylase in the principle enzyme activity which converts benzo(a)pyrene to toxic hydroxylated forms, the regulation of cytochrome P-450IA1 expression, the gene encoding this enzyme activity in MCF-7 cells, was examined. Incubation with 100 nM 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for 24 h results in a marked increase in aryl hydrocarbon hydroxylase activity in wild type (WT) but not Adr(R) MCF-7 cells. The alteration in aryl hydrocarbon hydroxylase expression in the Adr(R) cells is not overcome by incubation either with higher concentrations of TCDD (1 μM) or for longer periods of time (4 days). Northern blot analysis indicates that this defect in Adr(R) MCF-7 cells involves a regulatory defect at the level of P-450IA1 RNA. Following transfection of a construct containing the normal mouse P-450IA1 promoter fused to a reporter gene (bacterial chloramphenicol acetyltransferase) into WT and Adr(R) MCF-7 cells, TCDD induced chloramphenicol acetyltransferase activity in WT MCF-7 cells only. Furthermore, TCDD also induces both DT-diaphorase and UDP-glucuronyltransferase activities in WT, but not Adr(R) cells. These data suggest that the defect in the Adr(R) MCF-7 cells is not due to a structural P-450IA1 gene mutation, but rather involves a product regulating the polycyclic hydrocarbon-inducible expression of several drug-metabolizing enzyme activities. This defect in the Adr(R) MCF-7 cells is also associated with the development of resistance to ellipticine, an anticancer agent which is converted to more toxic hydroxylated species by aryl hydrocarbon hydroxylase or a similar mixed function oxidase. The WT and Adr(R) MCF-7 cells represent a useful model to study the regulation of the P-450IA1 gene in human cells.

AB - MCF-7 human breast cancer cells, selected for resistance to adriamycin (Adr(R)), exhibit the phenotype of multidrug resistance (MDR). Previous studies have shown that resistance in Adr(R) MCF-7 cells is associated with several biochemical changes that are similar to those induced in rat hyperplastic nodules, preneoplastic liver lesions which display broad spectrum resistance to carcinogens and hepatotoxins. In this report, we show that these changes in the Adr(R) MCF-7 cells are also associated with the development of cross-resistance to the procarcinogen benzo(a)pyrene (BP) and are associated with a marked defect in the conversion of BP to its cytotoxic, carcinogenic metabolites by Adr(R) cells. Since aryl hydrocarbon hydroxylase in the principle enzyme activity which converts benzo(a)pyrene to toxic hydroxylated forms, the regulation of cytochrome P-450IA1 expression, the gene encoding this enzyme activity in MCF-7 cells, was examined. Incubation with 100 nM 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for 24 h results in a marked increase in aryl hydrocarbon hydroxylase activity in wild type (WT) but not Adr(R) MCF-7 cells. The alteration in aryl hydrocarbon hydroxylase expression in the Adr(R) cells is not overcome by incubation either with higher concentrations of TCDD (1 μM) or for longer periods of time (4 days). Northern blot analysis indicates that this defect in Adr(R) MCF-7 cells involves a regulatory defect at the level of P-450IA1 RNA. Following transfection of a construct containing the normal mouse P-450IA1 promoter fused to a reporter gene (bacterial chloramphenicol acetyltransferase) into WT and Adr(R) MCF-7 cells, TCDD induced chloramphenicol acetyltransferase activity in WT MCF-7 cells only. Furthermore, TCDD also induces both DT-diaphorase and UDP-glucuronyltransferase activities in WT, but not Adr(R) cells. These data suggest that the defect in the Adr(R) MCF-7 cells is not due to a structural P-450IA1 gene mutation, but rather involves a product regulating the polycyclic hydrocarbon-inducible expression of several drug-metabolizing enzyme activities. This defect in the Adr(R) MCF-7 cells is also associated with the development of resistance to ellipticine, an anticancer agent which is converted to more toxic hydroxylated species by aryl hydrocarbon hydroxylase or a similar mixed function oxidase. The WT and Adr(R) MCF-7 cells represent a useful model to study the regulation of the P-450IA1 gene in human cells.

UR - http://www.scopus.com/inward/record.url?scp=0024215281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024215281&partnerID=8YFLogxK

M3 - Article

VL - 263

SP - 19119

EP - 19125

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 35

ER -